NCT01330485 Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive Disorder Status COMPLETED Phase NA
NCT01325532 Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD) Status COMPLETED Phase NA
NCT01323478 Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults Status COMPLETED Phase PHASE3
NCT01318434 A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) Status COMPLETED Phase PHASE2/PHASE3
NCT01312922 Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE3
NCT01310140 Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features Status TERMINATED Phase N/A
NCT01309776 Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder Status COMPLETED Phase PHASE4
NCT01309542 Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT01305889 The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed Elders Status COMPLETED Phase NA
NCT01299272 A Study in Prevention of Re-emergence of Depression Symptoms Status COMPLETED Phase PHASE3
NCT01288079 A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. Status TERMINATED Phase PHASE2
NCT01273376 Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder Status COMPLETED Phase PHASE2
NCT01269710 Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study Status COMPLETED Phase N/A
NCT01263223 A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors Status COMPLETED Phase PHASE1